| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | nuclear membrane | 1.50e-04 | 349 | 31 | 5 | GO:0031965 | |
| MousePheno | embryonic lethality before implantation | 3.40e-06 | 242 | 25 | 6 | MP:0006204 | |
| MousePheno | embryonic lethality before implantation, complete penetrance | 2.58e-05 | 203 | 25 | 5 | MP:0011094 | |
| MousePheno | embryonic lethality prior to organogenesis, complete penetrance | 3.89e-05 | 772 | 25 | 8 | MP:0014259 | |
| MousePheno | embryonic lethality prior to tooth bud stage, complete penetrance | 4.15e-05 | 779 | 25 | 8 | MP:0014257 | |
| MousePheno | embryonic lethality prior to tooth bud stage | PSMD4 RANBP2 ZNF830 SUPT6H DHX37 GFPT1 MATR3 DNAJC2 NUFIP1 RNF20 | 7.06e-05 | 1383 | 25 | 10 | MP:0013293 |
| MousePheno | embryonic lethality prior to organogenesis | 1.45e-04 | 1204 | 25 | 9 | MP:0013292 | |
| Domain | S1 | 1.19e-04 | 10 | 31 | 2 | PS50126 | |
| Domain | S1 | 1.74e-04 | 12 | 31 | 2 | SM00316 | |
| Domain | S1_domain | 1.74e-04 | 12 | 31 | 2 | IPR003029 | |
| Domain | S1_dom | 1.74e-04 | 12 | 31 | 2 | IPR022967 | |
| Domain | TPR_1 | 4.41e-04 | 90 | 31 | 3 | PF00515 | |
| Domain | TPR_1 | 4.41e-04 | 90 | 31 | 3 | IPR001440 | |
| Domain | Cyclophilin-type_PPIase_CS | 4.48e-04 | 19 | 31 | 2 | IPR020892 | |
| Domain | Pro_isomerase | 6.03e-04 | 22 | 31 | 2 | PF00160 | |
| Domain | - | 6.03e-04 | 22 | 31 | 2 | 2.40.100.10 | |
| Domain | Cyclophilin-type_PPIase_dom | 6.03e-04 | 22 | 31 | 2 | IPR002130 | |
| Domain | Cyclophilin-like_dom | 6.03e-04 | 22 | 31 | 2 | IPR029000 | |
| Domain | CSA_PPIASE_1 | 6.03e-04 | 22 | 31 | 2 | PS00170 | |
| Domain | CSA_PPIASE_2 | 6.03e-04 | 22 | 31 | 2 | PS50072 | |
| Domain | ZnF_U1 | 1.05e-03 | 29 | 31 | 2 | SM00451 | |
| Domain | Znf_U1 | 1.05e-03 | 29 | 31 | 2 | IPR003604 | |
| Domain | TPR | 1.26e-03 | 129 | 31 | 3 | SM00028 | |
| Domain | TPR_repeat | 1.37e-03 | 133 | 31 | 3 | IPR019734 | |
| Domain | TPR-contain_dom | 1.94e-03 | 150 | 31 | 3 | IPR013026 | |
| Domain | TPR | 2.54e-03 | 165 | 31 | 3 | PS50005 | |
| Domain | TPR_REGION | 2.54e-03 | 165 | 31 | 3 | PS50293 | |
| Domain | - | 4.80e-03 | 207 | 31 | 3 | 1.25.40.10 | |
| Domain | Prefoldin | 6.34e-03 | 72 | 31 | 2 | IPR009053 | |
| Domain | TPR-like_helical_dom | 6.66e-03 | 233 | 31 | 3 | IPR011990 | |
| Domain | NA-bd_OB-fold | 8.35e-03 | 83 | 31 | 2 | IPR012340 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | RRP15 PSMD4 RANBP2 CAPRIN1 SUPT6H DHX37 KIF20B MATR3 RNF20 TTC14 | 8.52e-09 | 989 | 31 | 10 | 36424410 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RRP15 PSMD4 RANBP2 EIF2A CAPRIN1 DHX37 KIF20B GFPT1 GOLGA4 MATR3 RNF20 | 1.23e-08 | 1353 | 31 | 11 | 29467282 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RRP15 PSMD4 RANBP2 CAPRIN1 SUPT6H DHX37 GFPT1 GOLGA4 MATR3 RNF20 | 2.61e-07 | 1425 | 31 | 10 | 30948266 |
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 29685955 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | 2.67e-06 | 1415 | 31 | 9 | 28515276 | |
| Pubmed | 4.06e-06 | 272 | 31 | 5 | 31010829 | ||
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 24441044 | ||
| Pubmed | 1.01e-05 | 1247 | 31 | 8 | 27684187 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 1.07e-05 | 1257 | 31 | 8 | 36526897 | |
| Pubmed | 1.58e-05 | 1327 | 31 | 8 | 32694731 | ||
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 2.04e-05 | 182 | 31 | 4 | 32239614 | |
| Pubmed | Identification of novel M phase phosphoproteins by expression cloning. | 2.15e-05 | 8 | 31 | 2 | 8885239 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 2.34e-05 | 665 | 31 | 6 | 30457570 | |
| Pubmed | 2.39e-05 | 1007 | 31 | 7 | 34597346 | ||
| Pubmed | 2.50e-05 | 1014 | 31 | 7 | 32416067 | ||
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | 3.14e-05 | 701 | 31 | 6 | 30196744 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | 3.22e-05 | 704 | 31 | 6 | 29955894 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 3.76e-05 | 724 | 31 | 6 | 36232890 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 4.10e-05 | 440 | 31 | 5 | 34244565 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 5.46e-05 | 774 | 31 | 6 | 15302935 | |
| Pubmed | 5.55e-05 | 469 | 31 | 5 | 37314180 | ||
| Pubmed | 5.72e-05 | 472 | 31 | 5 | 38943005 | ||
| Pubmed | 6.38e-05 | 483 | 31 | 5 | 36912080 | ||
| Pubmed | 6.46e-05 | 87 | 31 | 3 | 24169447 | ||
| Pubmed | 6.95e-05 | 14 | 31 | 2 | 32005751 | ||
| Pubmed | 7.04e-05 | 250 | 31 | 4 | 33536335 | ||
| Pubmed | 8.02e-05 | 15 | 31 | 2 | 20676357 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | 1.11e-04 | 1284 | 31 | 7 | 17353931 | |
| Pubmed | 1.12e-04 | 1285 | 31 | 7 | 35914814 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.14e-04 | 283 | 31 | 4 | 30585729 | |
| Pubmed | 1.30e-04 | 19 | 31 | 2 | 31186351 | ||
| Pubmed | 1.60e-04 | 21 | 31 | 2 | 37422473 | ||
| Pubmed | 1.67e-04 | 1371 | 31 | 7 | 36244648 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 1.72e-04 | 954 | 31 | 6 | 36373674 | |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 1.73e-04 | 316 | 31 | 4 | 31665637 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | 1.86e-04 | 607 | 31 | 5 | 39147351 | |
| Pubmed | 1.89e-04 | 971 | 31 | 6 | 33306668 | ||
| Pubmed | 2.15e-04 | 1429 | 31 | 7 | 35140242 | ||
| Pubmed | 2.27e-04 | 1442 | 31 | 7 | 35575683 | ||
| Pubmed | 2.39e-04 | 641 | 31 | 5 | 36057605 | ||
| Pubmed | 2.61e-04 | 653 | 31 | 5 | 22586326 | ||
| Pubmed | 2.64e-04 | 655 | 31 | 5 | 35819319 | ||
| Pubmed | 2.74e-04 | 660 | 31 | 5 | 32780723 | ||
| Pubmed | 2.74e-04 | 1487 | 31 | 7 | 33957083 | ||
| Pubmed | 2.85e-04 | 360 | 31 | 4 | 33111431 | ||
| Pubmed | 2.86e-04 | 1497 | 31 | 7 | 31527615 | ||
| Pubmed | 2.93e-04 | 145 | 31 | 3 | 28846114 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 2.94e-04 | 363 | 31 | 4 | 14691545 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 3.16e-04 | 370 | 31 | 4 | 22922362 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 3.23e-04 | 150 | 31 | 3 | 28242625 | |
| Pubmed | 3.33e-04 | 689 | 31 | 5 | 36543142 | ||
| Pubmed | 3.85e-04 | 711 | 31 | 5 | 33022573 | ||
| Pubmed | 4.21e-04 | 725 | 31 | 5 | 27025967 | ||
| Pubmed | 4.24e-04 | 34 | 31 | 2 | 25505242 | ||
| Pubmed | 4.42e-04 | 733 | 31 | 5 | 34672954 | ||
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 4.70e-04 | 411 | 31 | 4 | 35182466 | |
| Pubmed | 4.74e-04 | 1153 | 31 | 6 | 29845934 | ||
| Pubmed | Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. | 5.02e-04 | 37 | 31 | 2 | 20453842 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 5.18e-04 | 759 | 31 | 5 | 35915203 | |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 5.42e-04 | 179 | 31 | 3 | 36261009 | |
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | 5.69e-04 | 182 | 31 | 3 | 31067453 | |
| Pubmed | 6.12e-04 | 441 | 31 | 4 | 31239290 | ||
| Pubmed | 6.47e-04 | 42 | 31 | 2 | 34244791 | ||
| Pubmed | 6.65e-04 | 451 | 31 | 4 | 30033366 | ||
| Pubmed | Dynamic protein-protein interaction wiring of the human spliceosome. | 7.16e-04 | 197 | 31 | 3 | 22365833 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 8.07e-04 | 475 | 31 | 4 | 31040226 | |
| Pubmed | Identification of NPM-ALK interacting proteins by tandem mass spectrometry. | 8.11e-04 | 47 | 31 | 2 | 14968112 | |
| Pubmed | MLF2 Negatively Regulates P53 and Promotes Colorectal Carcinogenesis. | 8.45e-04 | 48 | 31 | 2 | 37438558 | |
| Pubmed | 8.50e-04 | 847 | 31 | 5 | 35850772 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | 8.50e-04 | 847 | 31 | 5 | 35235311 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 8.68e-04 | 1294 | 31 | 6 | 30804502 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 8.78e-04 | 853 | 31 | 5 | 28718761 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 8.85e-04 | 212 | 31 | 3 | 33853758 | |
| Interaction | CTNNB1 interactions | 1.42e-05 | 1009 | 31 | 9 | int:CTNNB1 | |
| Interaction | BIRC3 interactions | RRP15 PSMD4 RANBP2 CAPRIN1 SUPT6H DHX37 GFPT1 GOLGA4 MATR3 RNF20 | 1.92e-05 | 1334 | 31 | 10 | int:BIRC3 |
| Interaction | CDK9 interactions | 6.55e-05 | 685 | 31 | 7 | int:CDK9 | |
| Interaction | PA2G4 interactions | 6.75e-05 | 284 | 31 | 5 | int:PA2G4 | |
| Interaction | TP63 interactions | 9.31e-05 | 304 | 31 | 5 | int:TP63 | |
| Interaction | PIH1D1 interactions | 9.86e-05 | 731 | 31 | 7 | int:PIH1D1 | |
| Interaction | SGF29 interactions | 1.12e-04 | 164 | 31 | 4 | int:SGF29 | |
| Interaction | FMR1 interactions | 1.44e-04 | 536 | 31 | 6 | int:FMR1 | |
| Interaction | SMYD2 interactions | 1.48e-04 | 67 | 31 | 3 | int:SMYD2 | |
| GeneFamily | Cyclophilin peptidylprolyl isomerases | 1.58e-04 | 19 | 18 | 2 | 909 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.91e-04 | 115 | 18 | 3 | 769 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | 1.87e-05 | 1024 | 31 | 8 | M1742 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | 2.60e-05 | 1072 | 31 | 8 | MM1031 | |
| Coexpression | GSE40274_CTRL_VS_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 4.69e-05 | 170 | 31 | 4 | M9091 | |
| Coexpression | GSE40493_BCL6_KO_VS_WT_TREG_UP | 5.48e-05 | 177 | 31 | 4 | M9401 | |
| Coexpression | GSE40666_UNTREATED_VS_IFNA_STIM_CD8_TCELL_90MIN_DN | 8.64e-05 | 199 | 31 | 4 | M9227 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4MID_SORTED_BCELL_UP | 8.81e-05 | 200 | 31 | 4 | M9833 | |
| Coexpression | GRUETZMANN_PANCREATIC_CANCER_DN | 8.81e-05 | 200 | 31 | 4 | M10431 | |
| Coexpression | IBRAHIM_NRF1_UP | 1.24e-04 | 420 | 31 | 5 | M42509 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_UP | 1.34e-04 | 84 | 31 | 3 | M15130 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_UP | 1.43e-04 | 86 | 31 | 3 | MM825 | |
| Coexpression | UEDA_CENTRAL_CLOCK | 1.64e-04 | 90 | 31 | 3 | M2637 | |
| Coexpression | UEDA_CENTRAL_CLOCK | 1.81e-04 | 93 | 31 | 3 | MM1141 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Drd1_(Deep_layer_pyramidal_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.56e-06 | 176 | 31 | 4 | 3c76a5c4ca2b378667cb155fbb9675519572b35d | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-Activated_T|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.69e-06 | 189 | 31 | 4 | c38157c8cf5c0c1f560011ef5cc5892a049ee2b7 | |
| ToppCell | Caecum-Dendritic_cell-cycling_DCs|Dendritic_cell / Region, Cell class and subclass | 8.87e-06 | 190 | 31 | 4 | 54463f6f1718f22704175bd034f134de3b55d2eb | |
| ToppCell | CTRL-Lymphoid-T_cell_&_NK_cell|Lymphoid / Disease state, Lineage and Cell class | 9.05e-06 | 191 | 31 | 4 | 32381d353e40bce77a5b63c7bdbe360d27327d86 | |
| Drug | geldanamycin; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 3.00e-06 | 174 | 30 | 5 | 972_UP | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 6.91e-05 | 169 | 30 | 4 | 1056_UP | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 7.39e-05 | 172 | 30 | 4 | 1064_UP | |
| Drug | geldanamycin; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 7.73e-05 | 174 | 30 | 4 | 864_UP | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 7.73e-05 | 174 | 30 | 4 | 1063_UP | |
| Drug | geldanamycin; Up 200; 1uM; MCF7; HT_HG-U133A | 8.08e-05 | 176 | 30 | 4 | 5588_UP | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 8.26e-05 | 177 | 30 | 4 | 6943_UP | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 8.63e-05 | 179 | 30 | 4 | 1005_UP | |
| Drug | geldanamycin; Up 200; 1uM; MCF7; HG-U133A | 9.20e-05 | 182 | 30 | 4 | 593_UP | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 9.20e-05 | 182 | 30 | 4 | 998_UP | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 9.40e-05 | 183 | 30 | 4 | 6937_UP | |
| Drug | 17-DMAG; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.11e-04 | 191 | 30 | 4 | 6933_UP | |
| Drug | Rescinnamin [24815-24-5]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 1.13e-04 | 192 | 30 | 4 | 2785_DN | |
| Drug | Naloxone hydrochloride [357-08-4]; Down 200; 11uM; PC3; HG-U133A | 1.18e-04 | 194 | 30 | 4 | 1924_DN | |
| Drug | Dipyridamole [58-32-2]; Down 200; 8uM; PC3; HG-U133A | 1.20e-04 | 195 | 30 | 4 | 1934_DN | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Up 200; 13.4uM; HL60; HG-U133A | 1.27e-04 | 198 | 30 | 4 | 1377_UP | |
| Disease | microcephaly (implicated_via_orthology) | 4.23e-04 | 32 | 28 | 2 | DOID:10907 (implicated_via_orthology) | |
| Disease | longitudinal BMI measurement | 2.75e-03 | 82 | 28 | 2 | EFO_0005937 | |
| Disease | celiac disease | 6.36e-03 | 126 | 28 | 2 | EFO_0001060 | |
| Disease | breast cancer (is_implicated_in) | 8.90e-03 | 150 | 28 | 2 | DOID:1612 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KEAEIIKQLKIELKK | 621 | Q5VTR2 | |
| KEAKIKELLKKLEQL | 926 | Q8N283 | |
| IDKKLRNLEKKKGKL | 61 | Q14444 | |
| LLAKKEKDIQKKAIK | 336 | Q99543 | |
| WKKVLPLLKIIKKKN | 606 | P49792 | |
| KKKLKKVDKIEELDQ | 711 | P43243 | |
| VIIKKQKEIIKKLIE | 661 | Q92831 | |
| KKKLLDQEAKLKKEL | 971 | Q13439 | |
| EDLKKKLINEKKEKL | 581 | Q96Q89 | |
| NKEVKKALLKLKDKV | 291 | Q8NGN5 | |
| KKVKELIEKEKEKDL | 1091 | P29375 | |
| DLKKLRVKELKKILD | 131 | P55145 | |
| EQKREKILELKKKEK | 421 | Q9Y2L6 | |
| KILELKKKEKLLQEK | 426 | Q9Y2L6 | |
| KKKEKLLQEKLLKKV | 431 | Q9Y2L6 | |
| LLQEKLLKKVEELKK | 436 | Q9Y2L6 | |
| SDPLIEKQKLKKKLK | 1036 | P01031 | |
| LKELKILKDKKDAKI | 606 | Q5M9N0 | |
| KIKNLKKKLKAIEQL | 536 | Q9BY44 | |
| VKVILKKKKKLLLLQ | 81 | O75052 | |
| KKKKKLLLLQKKEWT | 86 | O75052 | |
| EKKVLQKILEQKEKK | 76 | Q8IY37 | |
| EKDLVKLAKRLKKEK | 121 | P55036 | |
| KIQLIKKKGKVKALD | 56 | Q06210 | |
| KKKLLKKQEQLKLKQ | 576 | Q9BXS9 | |
| ELLKVKQKIKAQKDK | 346 | Q08752 | |
| KEKEIKLLKLKYDEK | 246 | Q8NHV1 | |
| VKVLQKKAILKKKEE | 126 | O00141 | |
| KKLEELKLKKALEKQ | 456 | Q15172 | |
| KKLEELLIKTKKEKP | 1441 | Q7KZ85 | |
| KKKLKLEKEKRGAVL | 256 | Q9UHK0 | |
| EKLRKLLKEEKRLKK | 456 | Q96N46 | |
| ILVKNKKLEKEKEKL | 111 | Q9Y3B9 | |
| KKLEKEKEKLKQERL | 116 | Q9Y3B9 | |
| KLKEILTIKELQKKE | 331 | Q96NB3 | |
| KLILEELKLEKKIKI | 491 | P57075 |